Japanese Adverse Drug Event Report database

Open Access
Cardiovascular Adverse Events Associated With Carfilzomib, Bortezomib, and Ixazomib: A Disproportionality Analysis Using the Japanese Adverse Drug Event Report Database With Anticancer Agents as the Reference Group
MASAKI FUJIWARA, SHUJI NAGANO, YOSHIHIRO UESAWA, MAYAKO UCHIDA, NOBUYUKI MUROI and TADASHI SHIMIZU

In Vivo March 2026, 40 (2) 1019-1030; DOI: https://doi.org/10.21873/invivo.14257
Open Access
Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report database
YUKO KANBAYASHI, RISA MORIOKA, KOICHI TAKAYAMA and KEIKO HOSOHATA

In Vivo November 2025, 39 (6) 3453-3460; DOI: https://doi.org/10.21873/invivo.14143
Open Access
Association Between Anticholinergic Drug Use and Febrile Neutropenia Induced by Anticancer Chemotherapy: Analysis of the Japanese Adverse Drug Event Report Database
ANNA KATO-OGISO, TOMOHIRO MIZUNO, KOKI KATO, FUMIHIRO MIZOKAMI, SHO HASEGAWA, TSUYOSHI NAKAI, YOSUKE ANDO, MASAKAZU HATANO, TAKENAO KOSEKI and SHIGEKI YAMADA

In Vivo September 2025, 39 (5) 2872-2882; DOI: https://doi.org/10.21873/invivo.14087
Open Access
Risk Factors Associated With Thrombocytopenia Induced by Intravenous Immunoglobulin Formulations: An Analysis Using the JADER database
YOSHIHIRO NISHITA, NATSUKO ISHIDA, HIROFUMI NAGAI, TOGEN MASAUJI and JUNKO ISHIZAKI

In Vivo July 2025, 39 (4) 2320-2327; DOI: https://doi.org/10.21873/invivo.14028
Open Access
Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database
MASAKI FUJIWARA, HIROAKI IKESUE, KENTA YAMAOKA, MAYAKO UCHIDA, YOSHIHIRO UESAWA, NOBUYUKI MUROI and TADASHI SHIMIZU

In Vivo January 2025, 39 (1) 396-403; DOI: https://doi.org/10.21873/invivo.13841
Open Access
Anamorelin and Conduction Defects: A Literature Review and Analysis of the Japanese Pharmacovigilance Database
NAOHIRO YABUKI, KEN-ICHI SAKO, TOMOJI MAEDA and NAOHITO IDE

In Vivo January 2025, 39 (1) 404-410; DOI: https://doi.org/10.21873/invivo.13842
Open Access
Central Nervous System Adverse Reactions to Amantadine Intoxication: A Case Report and Analysis of JADER
NAOHITO IDE, YUI HOSOYA, MARIKO YAMAMOTO, AYAMI SHIGENO, MASAKAZU OBAYASHI, KEI ASADA and SATORU MATSUSHIMA

In Vivo July 2024, 38 (4) 2090-2096; DOI: https://doi.org/10.21873/invivo.13669
Open Access
Time-to-onset Analysis of Rhabdomyolysis due to Different Proton Pump Inhibitors Using a Pharmacovigilance Database
KATSUHIRO OHYAMA, MEGUMI IIDA, SHOTA AKIYAMA, HIROSHI YAMAZAKI and YUSUKE HORI

In Vivo May 2024, 38 (3) 1285-1291; DOI: https://doi.org/10.21873/invivo.13567
Open Access
Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database
KAORI ITO, TAKENAO KOSEKI, MISAKI MORISAKU, SHIGEKI YAMADA and NOBUKI HAYAKAWA

In Vivo March 2024, 38 (2) 923-927; DOI: https://doi.org/10.21873/invivo.13520
Open Access
Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database
KATSUHIRO OHYAMA, SHOTA AKIYAMA, MEGUMI IIDA and YUSUKE HORI

In Vivo November 2023, 37 (6) 2719-2725; DOI: https://doi.org/10.21873/invivo.13382

Main menu

User menu

Search

Japanese Adverse Drug Event Report database

Pages